EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Comparative analysis of gut microbiota in incident and prevalent peritoneal dialysis patients with peritoneal fibrosis, correlations with peritoneal equilibration test data in the peritoneal fibrosis cohort

Jiangqing Fan iD, Lingyun Wang, Ting Yang, Jing Liu, Weihong Ge, Jizhong Shen, Lulu Wang

Therapeutic Apheresis and Dialysis · 2026

DOI: 10.1111/1744-9987.14226 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Therapeutic Apheresis and Dialysis, 2026. Verfasst von Jiangqing Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Nanjing Drum Tower Hospital, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Peritoneal Fibrosis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Hospital Pharmacy Research Foundation of Changzhou Siyao Hospital and Nanjing Pharmaceutical Association, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The connection between peritoneal function and gut microbiota in peritoneal fibrosis (PF) patients remains uncertain.

Methods

Peritoneal equilibration test ( PET ) was employed to evaluate peritoneal function in patients with peritoneal fibrosis ( PF ). 16S rRNA sequencing was used to analyze the gut flora in incident peritoneal dialysis ( PD ) and PF groups, identifying differential microbial communities. Spearman's correlation analysis, conducted using SPSS 26.0, was employed to explore the microbial associations with PF .

Results

In the PF group, the PET showed a 4‐h dialysate‐to‐plasma creatinine ratio (D/PCr) ratio of 0.62 ± 1.01 and a 4‐h ultrafiltration (UF) volume of 41.73 ± 76.71 mL with a 2.5% glucose dwell. The alpha diversity between the PD and PF groups did not exhibit a significant difference. The PD and PF groups were predominantly composed of Firmicutes , Tenericutes , and Ignavibacteriae . Linear discriminant analysis effect size (LEfse) analysis indicates that the Firmicutes , Lactobacillales , and Bacilli were significantly enriched in the PD group, whereas Lachnospiraceae , Phenylobacterium , and Caulobacteraceae were enriched among the PF group. The functional prediction of gut microbiota genes revealed variations in metabolic pathways related to lipid transport, energy metabolism, and post‐translational protein modifications between the two cohorts. In the PF group, Ignavibacteriae and Bdellovibrio correlated positively with the 4‐h D/PCr ratio ( p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal DialysisPeritoneal FibrosisGastrointestinal MicrobiomeHumansMaleFemaleMiddle AgedRNA, Ribosomal, 16SDialysis SolutionsAdultCohort StudiesCreatinineAgedPeritoneum

Stichwörter der Autor:innen

16S rRNA sequencingend‐stage kidney diseasegut microbiotaperitoneal dialysisperitoneal fibrosis

Substanzen

RNA, Ribosomal, 16SDialysis SolutionsCreatinine

Autor:innen und Institutionen

  • Department of Pharmacy, Nanjing Drum Tower Hospital, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
  • Department of Pharmacy, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Department of Nephrology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, the "Double-First Class" Application Characteristic Discipline of Hunan Province (Pharmaceutical Science), Changsha M…

ORCID-Profile: Jiangqing Fan

Förderung

  • National Natural Science Foundation of China
  • Hospital Pharmacy Research Foundation of Changzhou Siyao Hospital and Nanjing Pharmaceutical Association
  • Fundamental Research Funds for the Central Universities
  • Jiangsu Research Hospital Association for Precision Medication
  • Foundation of Nanjing Medical Center for Clinical Pharmacy

Zitieren

APA

Fan, J., Wang, L., Yang, T., Liu, J., Ge, W., Shen, J., & Wang, L. (2026). Comparative analysis of gut microbiota in incident and prevalent peritoneal dialysis patients with peritoneal fibrosis, correlations with peritoneal equilibration test data in the peritoneal fibrosis cohort. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14226

Vancouver

Fan J, Wang L, Yang T, Liu J, Ge W, Shen J, et al. Comparative analysis of gut microbiota in incident and prevalent peritoneal dialysis patients with peritoneal fibrosis, correlations with peritoneal equilibration test data in the peritoneal fibrosis cohort. Therapeutic Apheresis and Dialysis. 2026. doi:10.1111/1744-9987.14226

BibTeX
@article{Fan2026,
  author = {Fan, Jiangqing and Wang, Lingyun and Yang, Ting and Liu, Jing and Ge, Weihong and Shen, Jizhong and Wang, Lulu},
  title = {Comparative analysis of gut microbiota in incident and prevalent peritoneal dialysis patients with peritoneal fibrosis, correlations with peritoneal equilibration test data in the peritoneal fibrosis cohort},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2026},
  doi = {10.1111/1744-9987.14226}
}
Kostenlos starten →